Yuyu Pharma Inc (000227) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.006x

Based on the latest financial reports, Yuyu Pharma Inc (000227) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩836.62 Million ≈ $566.97K USD) by net assets (₩139.10 Billion ≈ $94.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 000227 net asset quality score to measure how much of total assets are equity-financed.

Yuyu Pharma Inc - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Yuyu Pharma Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 000227 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Yuyu Pharma Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yuyu Pharma Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Greencoat UK Wind PLC LSE:UKW	0.042x
Western Alaska Minerals Corp V:WAM	-0.616x
Lantern Pharma Inc NASDAQ:LTRN	-0.477x
Naos Small Cap Opportunities Company Ltd AU:NSC	0.063x
Cannindah Resources Ltd AU:CAE	-0.041x
Karolinska Development AB ser. B ST:KDEV	-0.004x
HOYA Resort Hotel Group TWO:2736	0.038x
IT Link PA:ALITL	0.065x

Annual Cash Flow Conversion Efficiency for Yuyu Pharma Inc (2014–2024)

The table below shows the annual cash flow conversion efficiency of Yuyu Pharma Inc from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Yuyu Pharma Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩135.06 Billion ≈ $91.53 Million	₩24.95 Billion ≈ $16.91 Million	0.185x	+5182.83%
2023-12-31	₩120.36 Billion ≈ $81.56 Million	₩420.86 Million ≈ $285.21K	0.003x	+106.93%
2022-12-31	₩123.37 Billion ≈ $83.61 Million	₩-6.23 Billion ≈ $-4.22 Million	-0.050x	-244.10%
2021-12-31	₩128.69 Billion ≈ $87.21 Million	₩4.51 Billion ≈ $3.06 Million	0.035x	+253.64%
2020-12-31	₩117.04 Billion ≈ $79.31 Million	₩-2.67 Billion ≈ $-1.81 Million	-0.023x	-115.66%
2019-12-31	₩90.54 Billion ≈ $61.36 Million	₩13.19 Billion ≈ $8.94 Million	0.146x	+107.05%
2018-12-31	₩86.87 Billion ≈ $58.87 Million	₩6.11 Billion ≈ $4.14 Million	0.070x	+937.85%
2017-12-31	₩82.83 Billion ≈ $56.14 Million	₩561.35 Million ≈ $380.42K	0.007x	-94.60%
2016-12-31	₩78.29 Billion ≈ $53.06 Million	₩9.82 Billion ≈ $6.65 Million	0.125x	+179.12%
2015-12-31	₩73.73 Billion ≈ $49.97 Million	₩-11.68 Billion ≈ $-7.92 Million	-0.158x	-930.90%
2014-12-31	₩71.49 Billion ≈ $48.45 Million	₩1.36 Billion ≈ $923.95K	0.019x	--

About Yuyu Pharma Inc

KO:000227 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$29.39 Million

₩43.36 Billion KRW

Market Cap Rank

#23778 Global

#1615 in Korea

Share Price

₩7400.00

Change (1 day)

+5.26%

52-Week Range

₩6300.00 - ₩11670.00

All Time High

₩56262.57